Top Journalists
>
Stephen Feller

Stephen Feller

Author at Healio at Healio

Contact this person
Email address
s*****@*******.comGet email address
Influence score
24
Location
United States
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to AI PR

    View latest data and reach out all from one place
    Sign up to AI PR Toolkit

    Recent Articles

    healio.com

    FDA approves Moderna COVID-19 vaccine for some children

    The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval to those with at least one underlying condition that puts them at risk for severe disease.
    healio.com

    HIV funding cuts threaten to undo decades of progress

    Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of progress against the virus, researchers said this week.
    healio.com

    New Senate plan preserves PEPFAR funding

    The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with Trump administration priorities, but will apparently leave one critical public health program alone.Republican senators voted to amend the bill to remove a proposed $400 million cut to the U.S. President’s Emergency Plan for AIDS Relief, which had been caught up in
    healio.com

    HHS moves to remove thimerosal from influenza vaccines

    HHS announced on Wednesday that it has adopted a recommendation from a CDC committee to remove thimerosal from all influenza vaccines.
    healio.com

    Healio wins award for report on future of HIV vaccine research

    Healio received an APEX award for a 2024 report on the cloudy future of HIV vaccine research in the age of long-acting injectable medications that can protect people from the virus for months at a time.
    healio.com

    Oncologist who served as FDA’s chief medical officer, top vaccine o...

    A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the agency.HHS confirmed the departure of Vinay K. Prasad, MD, MPH, providing the following statement to Healio: “Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with
    healio.com

    HHS bars medical groups from CDC vaccine discussions

    HHS has barred several professional medical organizations from participating as outside liaisons to the CDC’s vaccine advisory committee.
    healio.com

    Rising resistance complicates management of aspergillosis

    Clinical management of aspergillosis has become more challenging as Aspergillus fumigatus develops increasing resistance to azoles, the antifungals primarily used to treat the infection, according to a review.
    healio.com

    First US case of New World screwworm confirmed in Maryland

    The first human case of New World screwworm infestation in the United States has been confirmed in a Maryland resident who returned from travel in Central America, according to health officials.
    healio.com

    FDA will review ensitrelvir for COVID-19 prevention

    The FDA on Tuesday accepted a new drug application from Shionogi to market ensitrelvir, an oral antiviral, as post-exposure prophylaxis for COVID-19, the company announced.
    healio.com

    Congo’s Ebola outbreak spreads as cases double

    An Ebola virus outbreak in the Democratic Republic of the Congo has doubled in size and spread in the province where it started, raising fears of cross-border spillover into neighboring Angola, a health official said.